Georgia vs Switzerland: HIV/AIDS deaths averted by antiretroviral therapy
Georgia
391.52 deaths
in 2024
Switzerland
398.9 deaths
in 2024
Georgia rank
97th
Switzerland rank
96th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Georgia
- Switzerland
How they compare
Switzerland currently reports 398.9 deaths against 391.52 deaths in Georgia, a difference of 7.38 deaths.
Across all 35 years both countries report, Switzerland has been ahead every year.
Georgia ranks 97th and Switzerland ranks 96th of 157 countries.
Switzerland has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Georgia | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 136.75 deaths | 136.75 deaths | Switzerland |
| 2000s | 21.22 deaths | 599.76 deaths | 578.54 deaths | Switzerland |
| 2010s | 188.92 deaths | 490.23 deaths | 301.31 deaths | Switzerland |
| 2020s | 359.78 deaths | 411.15 deaths | 51.36 deaths | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Georgia or Switzerland?
- Switzerland, at 398.9 deaths against 391.52 deaths in Georgia as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Georgia and Switzerland?
- 7.38 deaths, with Switzerland ahead.
- How many years of comparable data are there for Georgia and Switzerland?
- 35 years are reported by both, from 1990 to 2024.
- How do Georgia and Switzerland rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Georgia ranks 97th and Switzerland ranks 96th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.